Streamline Health Solutions (NASDAQ:STRM – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02, MarketWatch Earnings reports. Streamline Health Solutions had a negative return on equity of 35.03% and a negative net margin of 47.32%. The company had revenue of $5.77 million for the quarter.
Streamline Health Solutions Trading Up 3.6 %
Shares of NASDAQ STRM opened at $0.95 on Thursday. Streamline Health Solutions has a twelve month low of $0.80 and a twelve month high of $2.35. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.26. The stock has a fifty day simple moving average of $1.23 and a 200-day simple moving average of $1.50. The stock has a market capitalization of $55.79 million, a PE ratio of -4.12 and a beta of 1.27.
Wall Street Analysts Forecast Growth
Separately, StockNews.com assumed coverage on Streamline Health Solutions in a research report on Wednesday. They issued a “sell” rating on the stock.
Institutional Investors Weigh In On Streamline Health Solutions
Institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC grew its stake in shares of Streamline Health Solutions by 13.1% in the first quarter. Renaissance Technologies LLC now owns 281,769 shares of the company’s stock valued at $507,000 after buying an additional 32,700 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Streamline Health Solutions by 8.7% in the second quarter. Geode Capital Management LLC now owns 396,423 shares of the company’s stock valued at $503,000 after buying an additional 31,861 shares in the last quarter. Boothbay Fund Management LLC acquired a new stake in shares of Streamline Health Solutions in the first quarter valued at $333,000. Townsquare Capital LLC acquired a new stake in shares of Streamline Health Solutions in the fourth quarter valued at $224,000. Finally, HighTower Advisors LLC grew its stake in shares of Streamline Health Solutions by 10.5% in the fourth quarter. HighTower Advisors LLC now owns 105,000 shares of the company’s stock valued at $166,000 after buying an additional 9,950 shares in the last quarter. 34.60% of the stock is owned by institutional investors and hedge funds.
Streamline Health Solutions Company Profile
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Recommended Stories
- Five stocks we like better than Streamline Health Solutions
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Low-Cost ETFs That Are Crushing SPY
- How to Invest in Pharmaceutical Companies
- Shutterstock is the Value Stock they don’t want you to know about
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Body Slammed Under $100, Is World Wrestling Stock an Opportunity?
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.